PRIMARY PULMONARY MELIOIDOSIS WITH SECONDARY SEPTICAEMIA

P. KENNEDY KUMAR¹*, T. PREMAMALINI², K.S. SRIDHARAN³, T. DHANASEKAR⁴, U. ALMAS FATHIMA^5
1Department of Microbiology, Sri Ramachandra Medical College & Research Institute, Sri Ramachandra Institute of Higher Education, Porur, Chennai, 600116, India
²Department of Microbiology, Sri Ramachandra Medical College & Research Institute, Sri Ramachandra Institute of Higher Education, Porur, Chennai, 600116, India
³Department of Microbiology, Sri Ramachandra Medical College & Research Institute, Sri Ramachandra Institute of Higher Education, Porur, Chennai, 600116, India
⁴Department of Microbiology, Sri Ramachandra Medical College & Research Institute, Sri Ramachandra Institute of Higher Education, Porur, Chennai, 600116, India
⁵Department of Microbiology, Sri Ramachandra Medical College & Research Institute, Sri Ramachandra Institute of Higher Education, Porur, Chennai, 600116, India
* Corresponding Author : drtpremamalini@gmail.com

Received : 02-06-2019     Accepted : 26-06-2019     Published : 30-06-2019
Volume : 11     Issue : 6       Pages : 1606 - 1607
Int J Microbiol Res 11.6 (2019):1606-1607

Keywords : Pulmonary Melioidosis, Burkholderia pseudomalei, Polymyxin B, Latency & COPD
Conflict of Interest : None declared
Acknowledgements/Funding : Authors are thankful to Sri Ramachandra Medical College & Research Institute, Sri Ramachandra Institute of Higher Education, Porur, Chennai, 600116, India
Author Contribution : All authors equally contributed

Melioidosis is an emerging infection with increased mortality due to multi-organ involvement. We here with presenting a case of primary pulmonary Melioidosis with secondary septicaemia in a male patient 34year old patient. The patient was successfully treated with ceftazidime on timely and correct identification of the causative organism Burkholderia pseudomalei. Gram negative bacilli showing Polymyxin B resistance should give a clue for suspecting Burkholderia pseudomalei.

1. Cheng A.C., Currie B.J. (2005) Clin Microbiol Rev., 18(2), 383–416.
2. Adler N.R.L., Govan B., Cullinan M., Harper M., Adler B., Boyce J D. (2009) FEMS Microbiol Review, 33,1079–1099.
3. White N.J. (2003) Lancet, 361,1715–1722.
4. Currie B.J., Fisher D.A., Howard D.M., Burrow J.N., Lo D., et al. (2000) Clin Infect Dis., 31,981–986.
5. Currie B.J., Fisher D.A., Anstey N.M., Jacups S.P. (2000) Trans R Soc Trop Med Hyg., 94,301–304.
6. Chaowagul W., White N.J., Dance D.A., Wattanagoon Y., Naigowit P., et al. (1989) J Infect Dis., 159,890-9.
7. Flemma R.J., DiVincenti F.C., Dotin L.N., Pruitt B.A. Jr. (1969) Ann Thorac Surg., 7, 491-9.
8. Bateson E.M., Webling D.D. (1981) Australas Radiol., 25, 239-45.
9. Reechaipichitkul W. (2004) Southeast Asian J Trop Med Pub Health, 35, 664-9.
10. Mukhopadhyay A., Lee K.H., Tambyah P.A. (2004) J Infect., 48, 334-8.
11. Moore R.A., DeShazer D., Reckseidler S., Weissman A., Woods D. E. (1999) Antimicrob Agents and Chemother, 43,465–70.
12. Wuthiekanun V., Peacock S.J. (2006) Expert Rev. Anti Infect Ther., 4,445–55.
13. Chaowagul W., Simpson A.J., Suputtamongkol Y., White N.J. (1999) Clin Infect Dis., 28,1328.
14. Dhiensiri T., Puapairoj S., Susaengrat W. (1988) Radiology,166,711–15
15. Currie B.J., Fisher D.A., Howard D.M., Burrow J.N. (2000) Acta Trop., 74(2-3),145-51.